Bimix Std 001 (papaverine recalls

The FDA has published 1 recall involving Bimix Std 001 (papaverine since 2023. The latest was reported on 18 Jan 2023. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2023

Last 12 months0reported

Class I00% of total

Ongoing0latest 18 Jan 2023

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why bimix std 001 (papaverine is recalled

Sterility1100%

Companies

Northern VA Compounders Pllc1100%

By year

20231100%

All bimix std 001 (papaverine recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
18 Jan 2023Drug	CLASS II	BiMix STD 001 (Papaverine HCl/Phentolamine Mesylate) recalled	Northern VA Compounders Pllc	Sterility	Nationwide

Should you stop taking Bimix Std 001 (papaverine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.